Results 21 to 30 of about 5,486,230 (294)
Medicina, 2021 Background and objectives: Ovarian cancer is one of the leading causes of death among women worldwide. Most newly diagnosed ovarian cancer patients are diagnosed in advanced stages of the disease.
Changho Song +3 more
doaj +1 more source
Neoadjuvant chemotherapy in advanced-stage ovarian cancer – state of the art
Menopause Review, 2022 Ovarian cancer represents the fifth cause of cancer death among women, carrying one of the worst prognoses among gynaecological malignancies. The need to achieve no residual disease after surgery in order to optimize prognosis of advanced-stage ovarian ...
Chrysoula Margioula-Siarkou +7 more
doaj +1 more source
Management of Advanced Ovarian Cancer
Obstetrical & Gynecological Survey, 1984 Since the end of 1979 extensive pelvic lymphadenectomy has been performed at the Graz University Clinic of Obstetrics and Gynecology in the operative treatment of ovarian cancer in stages Ib to IV. In 27 of 48 patients (56.3%) positive nodes were found. The frequency of involved nodes in stage III only was 61.1% (N = 22).
E, Burghardt, H, Pickel, H, Stettner
openaire +2 more sources
Animal models of ovarian cancer. [PDF]
, 2003 Ovarian cancer is the most lethal of all of the gynecological cancers and can arise from any cell type of the ovary, including germ cells, granulosa or stromal cells.
Jean-François Ethier +11 more
core +1 more source
Gynecologic Oncology Reports, 2019 Low-grade serous ovarian cancer represents a minority of ovarian cancers and has distinctive features from high grade epithelial ovarian cancer. While less aggressive, in advanced stage they can be poorly chemo-responsive and incur a treatment challenge.
Miriam Champer +2 more
doaj +1 more source
Ovarian cancer immunotherapy: opportunities, progresses and challenges
Journal of Hematology & Oncology, 2010 Due to the low survival rates from invasive ovarian cancer, new effective treatment modalities are urgently needed. Compelling evidence indicates that the immune response against ovarian cancer may play an important role in controlling this disease.
Stevens Richard +5 more
doaj +1 more source
Molecular Cancer, 2014 AMP-activated protein kinase (AMPK) is a key energy sensor that is involved in regulating cell metabolism. Our previous study revealed that the subunits of the heterotimeric AMPK enzyme are diversely expressed during ovarian cancer progression.
Cuilan Li +5 more
doaj +1 more source
Can Nidogen-1 and Nidogen-2 improve our preoperative cancer detection rate?
Journal of Pre-Clinical and Clinical Research, 2021 Introduction and objective Ovarian cancer (OC) is the third most commonly diagnosed gynecological cancer among women worldwide and the second most common in Poland. Early-stage ovarian cancer is still very difficult to diagnose and concerns only about 20–
Agnieszka Kwiatkowska +2 more
doaj +1 more source
Paraneoplastic thrombocytosis in ovarian cancer [PDF]
, 2012 <p>Background: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear.</p> <p>Methods: We analyzed clinical data on 619 patients with epithelial ...
Han, H.D. +33 more
core +1 more source
Neoadjuvant chemotherapy for advanced ovarian cancer
International Journal of Gynecology & Obstetrics, 1994 The purpose of this study was to compare the survival of women with clinical, radiologic, and histologic findings compatible with advanced ovarian cancer who were treated with neoadjuvant chemotherapy to that of a group of women with FIGO stage IIIC (suboptimal debulking) and stage IV epithelial ovarian cancers treated with the same chemotherapy ...
P E, Schwartz, J T, Chambers, R, Makuch
openaire +2 more sources